every woman is getting on ozempic

=== SUMMARY === - Author argues GLP-1/Ozempic weight-loss trend will drive women to buy sexy clothing at Victoria’s Secret, making VSCO a better buy than S&P 500 or NVDA. - The thesis is based on an anecdotal behavioral observation plus VSCO’s 300% stock rally last year; there is no fundamental valuation or sales analysis. - Overall quality: speculative social/narrative trading, not well-researched DD. It is essentially momentum-chasing with a catchy consumer trend story. === SENTIMENT === BULLISH === TRADE IDEAS === VSCO - LONG | confidence: 0.60 | sentiment: +0.70 Speaker: u/iam_horny6969420 Thesis: 1. THE FACT: Author claims Ozempic-driven weight loss leads women to shop for sexy clothes, especially Victoria’s Secret; notes VSCO rose ~300% last year. 2. THE BRIDGE: Weight-loss drug adoption is a structural consumer shift that could flow into apparel/innerwear spending, creating a momentum narrative for VSCO. 3. THE VERDICT: Buy VSCO as a post-Ozempic consumer-discretionary play rather than index or tech exposure. 4. RISKS: The trade may be late/priced in; commenters cite poor brand perception, basic product selection, loose skin, and “Ozempic face” weakening the sexy-retail thesis. Timeframe: medium-term Key Points: - Author explicitly says "buy victoria secret" - Thesis: Ozempic users buy sexy clothes after weight loss - Stock already up 300% last year — maybe priced in - Comments: "you're not wrong but late" and "giga-priced in" - No valuation, margins, or sales data provided === COMMENTS SUMMARY === Top commenters largely pushed back, saying the idea is late and likely priced in, with one comparing it to last year’s Lululemon trade. Others questioned the consumer thesis: a stepmom on Ozempic isn’t losing weight, Victoria’s Secret has a basic/small selection, and loose skin or “Ozempic face” may reduce the desire for sexy clothing. Overall, community sentiment is skeptical and treats the post as a meme rather than actionable DD.